NeuroLicensing 2021 is our completely revised/updated review of current trends in deal parameters, focusing on the major and midsize companies who are involved in CNS licensing. Opportunities and licensing agendas/performance are candidly appraised. A practical and affordable resource for licensing efforts on both sides of the transaction, both potential licensors and licensees. 104 pages. Released February 2021.      US$4200